IntegriChain CEO and leadership

With more than 20 years of experience in life sciences therapy commercialization, data, and analytics, Josh Halpern is responsible for IntegriChain’s product vision and go-to-market strategy. From IntegriChain’s founding in 2006 through its initial venture capital-backed growth, Josh led the development of IntegriChain’s market leading channel and patient data aggregation solutions. Following the company’s partnership with private equity (Accel KKR) in 2016, Josh worked with IntegriChain’s Board and leadership team to create a drug commercialization services company and technology platform uniquely focused on Market Access. In the past four years, Josh has been a key leader in four successful acquisitions and their integration within the IntegriChain business and IntegriChain’s ICyte technology platform. In that time, the company has grown to more than 500 team members and 250 customers.Prior to co-founding IntegriChain, Josh served as Vice President of Business Development at Internet Crimes Group, where he spearheaded the company’s transformation into an Internet data mining platform that worked closely with pharmaceutical industry leaders during the counterfeit drug scare of the early 2000s. Josh is a frequent industry speaker and author on data-driven strategies for patient access and therapy commercialization.

Vickie Kozhushchenko leads IntegriChain’s global People and Culture organization, including talent acquisition, organization and talent development, and people operations. Her primary focus is on continuous development of company culture, aligning the company’s people strategy with its business drivers, and coaching and partnership with senior leaders. She delivers more than 25 years of global HR experience, including senior executive roles at Clean Earth, Aramark, Turner Broadcasting System, Comcast, and Coordinated Health as well as extensive acquisition integration experience. Her expertise is in engineering and re-engineering business processes, development of comprehensive talent management strategies, evaluation and implementation of human capital management systems, and the analysis and improvement of organizational systems through customized training, development, and coaching programs. Vickie earned a bachelor’s degree in business administration from Cornell University and a master’s degree in Organizational Dynamics from the University of Pennsylvania.

With more than 20 years of experience in life sciences therapy commercialization, data, and analytics, Josh Halpern is responsible for IntegriChain’s product vision and go-to-market strategy. From IntegriChain’s founding in 2006 through its initial venture capital-backed growth, Josh led the development of IntegriChain’s market leading channel and patient data aggregation solutions. Following the company’s partnership with private equity (Accel KKR) in 2016, Josh worked with IntegriChain’s Board and leadership team to create a drug commercialization services company and technology platform uniquely focused on Market Access. In the past four years, Josh has been a key leader in four successful acquisitions and their integration within the IntegriChain business and IntegriChain’s ICyte technology platform. In that time, the company has grown to more than 500 team members and 250 customers.Prior to co-founding IntegriChain, Josh served as Vice President of Business Development at Internet Crimes Group, where he spearheaded the company’s transformation into an Internet data mining platform that worked closely with pharmaceutical industry leaders during the counterfeit drug scare of the early 2000s. Josh is a frequent industry speaker and author on data-driven strategies for patient access and therapy commercialization.